As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres
Targeting deadly drug-resistant acinetobacter infections
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The facility sets a new benchmark in respiratory diagnostics
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
Subscribe To Our Newsletter & Stay Updated
